Home > Food & Beverages > Food Additives > Texturizers and Thickeners > Medium-chain Triglycerides Market

Medium-chain Triglycerides Market Analysis

Report ID: GMI5216
Published Date: Feb 2023
Report Format: PDF

Download Free Sample

Medium-chain Triglycerides Market Analysis

The medium-chain triglycerides market valuation from the palm source segment is poised to surpass USD 835 million by 2032. Palm seeds and kernels are widely used to manufacture MCTs due to their high production yield at 3.3t/ha as compared to rapeseed and sunflower with a 0.7t/ha yield. Palm oil is a rich source of MCTs and antioxidants offering numerous health benefits, including a healthy immune system. The growing health concerns associated with age-related macular degeneration, cardiovascular diseases, and certain cancers are also driving the consumer preference for a vitamin E-rich diet, further emphasizing on MCT oils produced from palm kernels.

The medium-chain triglycerides market share from food and beverage applications segment is anticipated to exhibit over 5.5% CAGR through 2032, powered by their extensive usage to manufacture functional foods. The rising prevalence of chronic diseases has propelled the demand for functional foods considering their ability to fight diseases, boost growth, and improve metabolic activity. Additionally, biologically active functional food components can prevent certain non-communicable diseases, such as osteoporosis, cancer, type 2 diabetes, and fluctuations in blood cholesterol. Hence, the growing consumer awareness regarding nutrition and health is expected to accelerate the market revenue.

Learn more about the key segments shaping this market

Download Free Sample

Asia Pacific medium-chain triglycerides market size is slated to reach USD 765 million by 2032, as the region is home to an expanding pharmaceutical sector with a massive raw material supply chain. Countries, such as China are one of the largest suppliers of pharmaceutical raw materials worldwide, offering lucrative business prospects for the leading manufacturers of MCTs. Due to the availability of cheap labor, low set-up costs, and affordable raw materials, APAC has attracted several foreign pharmaceutical giants. For instance, in May 2022, Ferring Pharma, a Swiss multinational biopharmaceutical company unveiled a new formulation facility in Hyderabad, India to manufacture Pentasa. The company pledged an investment of approximately USD 65 million over the coming 2-3 years.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of medium-chain triglycerides worth USD 1.3 billion in 2022 and is set to witness over 6% CAGR between 2023 and 2032.

The food & beverage applications segment is poised to expand at a CAGR of 5.5% from 2023 to 2032, due to surging use in the manufacturing of functional foods.

The market size for medium-chain triglycerides in Asia Pacific is projected to exceed USD 765 million by 2032, owing to the rising rate of pharmaceutical manufacturing.

BASF, Lonza, Croda International, Acme Hardesty, Stepan Company, KLK OLEO, and Sternchemie GMNH & CO. KG. are some of the major companies in the market.